Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of ARMA in Selective Subset of Refractory GERD Patients- A Randomized Sham Control Trial.

NCT05899491 is registered in ClinicalTrials.gov with Asian Institute of Gastroenterology, India as lead sponsor.

NCT NCT05899491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05899491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of ARMA in Selective Subset of Refractory GERD Patients- A Randomized Sham Control Trial.
Lead sponsor
Asian Institute of Gastroenterology, India
Phase
Not applicable
Overall status
Completed
Start date
March 30, 2023
Completion date
December 30, 2023
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gerd, reflux, reflux esophagitis